Targeted anticancer drugs block cancer cell growth by interfering with specific signaling
pathways vital to carcinogenesis and tumor growth rather than harming all rapidly dividing …

Although antibodies are well developed and widely used in cancer therapy and diagnostic
fields, some defects remain, such as poor tissue penetration, long in vivo metabolic …

Simple Summary Prostate and breast cancers are the most common malignancies. Accurate
diagnosis and staging of diseases are important for the prognosis and determination of …

Simple Summary The receptor HER2 is overexpressed in some breast cancers. Tumours
with a high HER2 expression can be successfully treated with the antibodies trastuzumab …

Non-invasive radionuclide molecular visualization of human epidermal growth factor
receptor type 2 (HER2) can provide stratification of patients for HER2-targeting therapy. This …

The recognition of biomolecules is crucial in key areas such as the timely diagnosis of
somatic and infectious diseases, food quality control, and environmental monitoring. This …

This review examines the evolution of the radionuclide diagnosis of HER2-positive breast
cancer using various compounds as a targeting module in clinical practice: from full-length …

Purpose Fluorescence-guided surgery (FGS) can play a key role in improving radical
resection rates by assisting surgeons to gain adequate visualization of malignant tissue …

Background Designed mimetic molecules are attractive tools in biopharmaceuticals and
synthetic biology. They require mass and functional production for the assessment of …

Non-invasive radionuclide imaging of human epidermal growth factor receptor type 2
(HER2) expression in breast, gastroesophageal, and ovarian cancers may stratify patients …